Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2010
05/14/2010WO2009134616A8 Novel inhibitors of hepatitis c virus replication
05/14/2010WO2009097515A3 [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
05/14/2010CA2742897A1 Modulators of amyloid beta.
05/14/2010CA2742744A1 Apparatus and method using rotary flow distribution mechanisms
05/14/2010CA2742741A1 Substituted disulfonamides
05/14/2010CA2742602A1 Gamma secretase modulators
05/14/2010CA2742552A1 Herbicidal compositions
05/14/2010CA2742317A1 Gamma secretase modulators
05/13/2010US20100121067 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
05/13/2010US20100121056 Pseudonucleotide comprising an intercalator
05/13/2010US20100121051 Urotensin ii receptor antagonists
05/13/2010US20100120841 Benzimidazole compound and pharmaceutical use thereof
05/13/2010US20100120840 tyrosine kinase inhibitors such as 1-Phenyl-ethyl)-(2-phenyl-3H-imidazo[4,5-b]pyridin-6-yl)-amine, used in the prevention and therapy of transplant rejection, inflammatory bowel disease, arthritis, psoriasis, restenosis, asthma, stroke, osteoporosis, cancer, Alzheimer's and Parkinson's disease
05/13/2010US20100120838 Compounds for the treatment of inflammatory disorders
05/13/2010US20100120818 Substituted tetrahydropyrroloquinolines
05/13/2010US20100120810 Compounds and methods for modulating rho gtpases
05/13/2010US20100120808 Spirocyclic heterocyclic derivatives and methods of their use
05/13/2010US20100120804 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/13/2010US20100120792 Substituted 2,3,4,5-Tetrahyrdo-1H-Pyrido[4,3-B]Indoles, Methods for the Production and Use Thereof
05/13/2010US20100120781 Novel Compounds for Treatment of Cancer and Disorders Associated with Angiogenesis Function
05/13/2010US20100120761 Bicyclic Heterocyclic Compounds as FGFR Inhibitors
05/13/2010US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives
05/13/2010US20100120730 6-benzyl-2,3,4,7-tetrahydro-indolo [2,3-c] quinoline compounds useful as pde5 inhibitors
05/13/2010US20100120717 Kinase inhibitors
05/13/2010US20100119764 Cyanine dye and optical recording medium
05/13/2010US20100119510 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
05/13/2010US20100119475 Novel inhibitors of glutaminyl cyclase
05/13/2010US20100115711 Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivative
05/12/2010EP2184285A1 Heterocyclic compound and use thereof
05/12/2010EP2184284A1 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as the active ingredient
05/12/2010EP2183251A1 Indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers
05/12/2010EP2183250A1 Naphthyridine derivatives as potassium channel modulators
05/12/2010EP2183243A2 Pyrazole compounds and their use as raf inhibitors
05/12/2010EP2183218A2 Novel b1 antagonists
05/12/2010EP2183217A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
05/12/2010EP2182805A2 Antiviral drugs for treatment of arenavirus infection
05/12/2010EP2069342B1 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
05/12/2010EP2032574B1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
05/12/2010EP1971605B1 Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators
05/12/2010EP1663219B1 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
05/12/2010EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
05/12/2010DE112008001507T5 Neue Hybridverbindungen von Nukleobasen und organischen Redox-Molekülen und ihre Verwendung New hybrid compounds of nucleobases and organic redox molecules and their use
05/12/2010CN1962658B Tetrahydropyridine [3,2-d] pyridine compound and its uses for preparing antineoplastic drug
05/12/2010CN1809572B Substituted quinobenzoxazine analogs
05/12/2010CN101704817A New matrine compound, preparation method thereof and applications thereof
05/12/2010CN101704816A Water-soluble perylene diimide derivatives containing N-pyridine oxide groups and synthetic method thereof
05/12/2010CN101704815A Method for preparing azepine indole compounds
05/12/2010CN101704814A Method for converting crystal form of risperidone
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101190915B Anti-thrombus N-butyl-2,2-dimethyl-4-oxy-tetrahydroimidazopyridoindole and its synthesis and application
05/12/2010CN101054377B Total alkaloids extraction of corydalis, its preparation method, medicine composition containing the total alkaloids extraction and application thereof
05/12/2010CN101041660B 1,2-dihydrogen pyridine derivative, carbon glycosides intermediate and preparation method and application thereof
05/11/2010US7714170 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
05/11/2010US7714136 Tetrahydropyridothiophenes
05/11/2010US7714135 Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
05/11/2010US7714134 Compounds and use of tetrahydropyridothiophenes
05/11/2010US7714132 Tetrahydropyridoindole derivatives
05/11/2010US7714019 Indole, azaindole and related heterocyclic pyrrolidine derivatives
05/11/2010US7714009 Nitrogen-containing fused heterocyclic compounds
05/11/2010US7713993 1-(4-fluorophenyl)-3-{(E)-2-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]vinyl}-6,7-dihydro-5H-imidazo-[1,5-a]pyrazin-8-one; for diseases caused by amyloid- beta is Alzheimer's disease, dementia, Down's syndrome or amyloidosis
05/11/2010US7713992 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders
05/11/2010US7713991 Imidazo[[1, 5-A] pyridine derivatives and methods for treating aldosterone mediated diseases
05/11/2010US7713989 Modulators and steroid receptors for treatment of diabetes, inflammatory diseases using prodrugs; arthritis, asthma, rhinitis and immunomodulation
05/11/2010US7713981 Method and compounds for inhibition of cell death
05/11/2010US7713977 Drug for psychological and central nervous system disorders
05/11/2010US7713976 Drug for psychological and central nervous system disorders
05/11/2010US7713974 3-chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)-phenoxy]-benzonitrile; inhibit HIV reverse transcriptase and are useful for treating Human Immunodeficiency Virus (HIV) mediated diseases
05/11/2010US7713969 Compositions and methods for treatment of cancer
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713954 Compositions and methods for treating cognitive disorders
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2415532C Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
05/11/2010CA2413134C Quinazoline ditosylate salt compounds
05/11/2010CA2344439C Process for the production of a naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate)
05/11/2010CA2326324C Nitrogen-containing heterocyclic compound
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050778A1 Novel compounds for organic electronic material and organic electronic device using the same
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010049731A1 Pyrazolo- and imidazopyridinylpyrimidineamines as igf-1r tyrosine kinase inhibitors
05/06/2010WO2010049635A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
05/06/2010WO2010049500A2 A process for the preparation of tadalafil.
05/06/2010WO2010049366A1 Tricyclic compounds as glutamate receptor modulators
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010WO2010049270A1 Substituted pyridines having a herbicidal effect
05/06/2010WO2010049269A1 Substituted pyridines having a herbicidal effect
05/06/2010WO2010030538A3 Compounds for the treatment of hepatitis c
05/06/2010WO2009153597A3 Compositions with and process for methylmorpholin-subsituted pyrido [2, 3-d] pyrimidines
05/06/2010WO2009151598A8 Diazacarbazoles and methods of use
05/06/2010WO2009143347A3 Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
05/06/2010WO2009106749A3 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
05/06/2010US20100113781 Substituted heterocycle gamma-carbolines synthesis
05/06/2010US20100113774 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
05/06/2010US20100113762 Apparatus and Method Using Rotary Flow Distribution Mechanisms
05/06/2010US20100113507 3-Tetrazolyl Indazoles, 3-Tetrazolyl Pyrazolopyridines, and use Thereof
05/06/2010US20100113505 Amino-naphthyridine derivatives
05/06/2010US20100113503 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
05/06/2010US20100113502 Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor Ligands
05/06/2010US20100113487 Pyrimidinone derivatives and methods of use thereof
05/06/2010US20100113478 Indolone modulators of 5-ht3 receptor
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 646